Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Dent J (Basel) ; 10(11)2022 Oct 27.
Artículo en Inglés | MEDLINE | ID: mdl-36354648

RESUMEN

Work-related exposures affecting oral health are important factors of morbidity and decreased quality of life, which may emerge from numerous physical, chemical, or mental occupational exposures. Copper (Cu) is an important trace element, however, it may also cause allergies, depose and accumulate in the body, leading to acute and chronic toxicity. In the present report, we describe a rare phenomenon found during the examination of two professional brass players, after incidentally noting an artefact during magnetic resonance imaging (MRI) scans, which were performed to monitor bone healing after bone augmentation procedures in an unrelated clinical study. During a detailed workup of patient characteristics, data on medical history, lifestyle, professional habits related to playing the instrument, and oral health status were collected. Overall, both patients presented with similar histories, and the differences from the context of this study were not relevant; however, both brass players were using an uncoated Cu mouthpiece for over 15 years. Based on the imaging findings (a shadow in the area of the lips on the MRI images) and the organoleptic evaluation of the lips and mucosa of the individuals (temporary faint green discoloration), it is most likely that the brass players were affected by oxidized Cu accumulation in the lip. In contrast to several professions, musicians are usually not required by law to attend obligatory occupational health check-ups, which may facilitate the occurrence of such exposures in musicians. Clinicians should be on the lookout for brass players involved in the profession for a long time, who may have used the mouthpieces for an extended period of time, in addition to musicians affected by Wilson's disease. In patients affected by this phenomenon, diagnostics of oral cancer and prosthodontic procedures may be cumbersome, due to the detrimental impact on the utility of MRI imaging from artefact-formation and scattering.

2.
Ann Clin Microbiol Antimicrob ; 16(1): 31, 2017 Apr 14.
Artículo en Inglés | MEDLINE | ID: mdl-28410611

RESUMEN

BACKGROUND: Scedosporium apiospermum is an emerging opportunistic filamentous fungus, which is notorious for its high levels of antifungal-resistance. It is able to cause localized cutaneous or subcutaneous infections in both immunocompromised and immunocompetent persons, pulmonary infections in patients with predisposing pulmonary diseases and invasive mycoses in immunocompromised patients. Subcutaneous infections caused by this fungus frequently show chronic mycetomatous manifestation. CASE REPORT: We report the case of a 70-year-old immunocompromised man, who developed a fungal mycetomatous infection on his right leg. There was no history of trauma; the aetiological agent was identified by microscopic examination and ITS sequencing. This is the second reported case of S. apiospermum subcutaneous infections in Hungary, which was successfully treated by surgical excision and terbinafine treatment. After 7 months, the patient remained asymptomatic. Considering the antifungal susceptibility and increasing incidence of the fungus, Scedosporium related subcutaneous infections reported in the past quarter of century in European countries were also reviewed. CONCLUSIONS: Corticosteroid treatment represents a serious risk factor of S. apiospermum infections, especially if the patient get in touch with manure-enriched or polluted soil or water. Such infections have emerged several times in European countries in the past decades. The presented data suggest that besides the commonly applied voriconazole, terbinafine may be an alternative for the therapy of mycetomatous Scedosporium infections.


Asunto(s)
Antifúngicos/administración & dosificación , Desbridamiento , Pierna/patología , Micetoma/diagnóstico , Micetoma/terapia , Naftalenos/administración & dosificación , Scedosporium/aislamiento & purificación , Anciano , Análisis por Conglomerados , ADN de Hongos/química , ADN de Hongos/genética , ADN Espaciador Ribosómico/química , ADN Espaciador Ribosómico/genética , Dermatomicosis/diagnóstico , Dermatomicosis/microbiología , Dermatomicosis/patología , Dermatomicosis/terapia , Humanos , Hungría , Huésped Inmunocomprometido , Masculino , Microscopía , Micetoma/microbiología , Micetoma/patología , Filogenia , Recurrencia , Scedosporium/clasificación , Scedosporium/citología , Scedosporium/genética , Análisis de Secuencia de ADN , Terbinafina , Resultado del Tratamiento
3.
Anaerobe ; 40: 31-4, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27036998

RESUMEN

A 76-year-old female patient was admitted to the Level I Emergency Department of University of Szeged with severe abdominal pain and vomiting. The clinical assessment with laboratory tests and radiological investigations confirmed severe sepsis associated with intravascular hemolysis and multiorgan failure and acute pancreatitis. On the abdominal CT, besides of other abnormalities, the presence of gas bubbles in the stomach, small intestines and liver were seen. The gastric alterations pointed to emphysematous gastritis. Despite of the medical treatment, the patient's condition quickly deteriorated and eight hours after admission the patient died. The autopsy evaluation revealed systemic infection of abdominal origin caused by gas-producing Gram-positive bacteria, and the post-mortem microbiological cultures confirmed the presence of Cloctridium perfringens in many abdominal organs. Emphysematous gastritis seemed to be the primary infectious focus.


Asunto(s)
Clostridium perfringens/patogenicidad , Enfisema/diagnóstico , Gangrena Gaseosa/diagnóstico , Gastritis/diagnóstico , Infecciones Intraabdominales/diagnóstico , Sepsis/diagnóstico , Anciano , Clostridium perfringens/crecimiento & desarrollo , Clostridium perfringens/aislamiento & purificación , Enfisema/microbiología , Enfisema/patología , Resultado Fatal , Femenino , Gangrena Gaseosa/microbiología , Gangrena Gaseosa/patología , Gastritis/microbiología , Gastritis/patología , Humanos , Infecciones Intraabdominales/microbiología , Infecciones Intraabdominales/patología , Sepsis/microbiología , Sepsis/patología
4.
Pediatr Allergy Immunol ; 27(5): 493-8, 2016 08.
Artículo en Inglés | MEDLINE | ID: mdl-26918853

RESUMEN

BACKGROUND: Regulations on medicinal products for paediatric use require that pharmacokinetics and safety be characterized specifically in the paediatric population. A previous study established that a 10-mg dose of bilastine in children aged 2 to <12 years provided an equivalent systemic exposure as 20 mg in adults. The current study assessed the safety and tolerability of bilastine 10 mg in children with allergic rhinoconjunctivitis and chronic urticaria. METHODS: In this phase III, multicentre, double-blind study, children were randomized to once-daily treatment with bilastine 10-mg oral dispersible table (n = 260) or placebo (n = 249) for 12 weeks. Safety evaluations included treatment-emergent adverse events (TEAEs), laboratory tests, cardiac safety (ECG recordings) and somnolence/sedation using the Pediatric Sleep Questionnaire (PSQ). RESULTS: The primary hypothesis of non-inferiority between bilastine 10 mg and placebo was demonstrated on the basis of a near-equivalent proportion of children in each treatment arm without TEAEs during 12 weeks' treatment (31.5 vs. 32.5%). No clinically relevant differences between bilastine 10 mg and placebo were observed from baseline to study end for TEAEs or related TEAEs, ECG parameters and PSQ scores. The majority of TEAEs were mild or moderate in intensity. TEAEs led to discontinuation of two patients treated with bilastine 10 mg and one patient treated with placebo. CONCLUSIONS: Bilastine 10 mg had a safety and tolerability profile similar to that of placebo in children aged 2 to <12 years with allergic rhinoconjunctivitis or chronic urticaria.


Asunto(s)
Bencimidazoles/uso terapéutico , Antagonistas de los Receptores Histamínicos H1 no Sedantes/uso terapéutico , Piperidinas/uso terapéutico , Rinitis Alérgica Perenne/tratamiento farmacológico , Urticaria/tratamiento farmacológico , Adolescente , Adulto , Niño , Preescolar , Enfermedad Crónica , Método Doble Ciego , Femenino , Estudios de Seguimiento , Humanos , Masculino , Resultado del Tratamiento
5.
Biol Trace Elem Res ; 124(3): 195-205, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18465090

RESUMEN

Severe hyperhomocysteinemia (HHC) is associated with atherosclerosis. In hemodialysis (HD) patients, one of the main causes of death is cardiovascular disease. In animals, trace elements such as cobalt, copper, iron, and nickel ameliorated vitamin B(12) deficiency-induced HHC. However, correlations between plasma total homocysteine (tHcy) and trace elements in HD patients have not been investigated. Therefore, tHcy, folate, vitamin B(12), trace elements (cobalt, copper, iron, and nickel), and some laboratory parameters such as serum total protein, albumin, transferrin, ferritin, C-reactive protein (CRP), and interleukin-6 concentrations were determined in 122 hemodialysis patients. When patients were divided into groups according to their tHcy, we found no significant differences in concentrations of cobalt, copper, and total protein, while nickel was higher, and folate, vitamin B(12), and iron were lower in patients with lower than higher tHcy. In univariate regression analysis, tHcy negatively correlated with concentrations of folate (r = -0.302, p < 0.006), vitamin B(12) (r = -0.347, p < 0.0001), nickel (r = -0.289, p < 0.006), and CRP (r = -0.230, p < 0.02) and positively with serum albumin (r = 0.316, p < 0.0004) and hemoglobin (r = 0.329, p < 0.0001) values. No relationship between tHcy and serum concentrations of cobalt, copper, iron, or other laboratory parameters was found in HD patients. The effect of cobalt and nickel on homocysteine production was assessed in human peripheral mononuclear cells (PBMCs). Nickel but not cobalt at concentrations found in HD patients significantly inhibited homocysteine, cysteine, and S-adenosylhomocysteine production in human PBMCs. These results suggest that nickel might also be involved in the regulation of the methionine-folate cycle in humans, as was demonstrated in animal experiments.


Asunto(s)
Homocisteína/sangre , Níquel/sangre , Diálisis Renal , Anciano , Proteína C-Reactiva/metabolismo , Femenino , Humanos , Interleucina-6/sangre , Masculino , Persona de Mediana Edad , Análisis de Regresión , Oligoelementos/sangre , Vitamina B 12/sangre
6.
Eur J Immunol ; 38(1): 147-55, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18085670

RESUMEN

Vitamin A deficiency is known to be accompanied with immune deficiency and susceptibility to a wide range of infectious diseases. Experimental evidence suggests that the active metabolites of vitamin A that mediate its effects on the immune system are the retinoic acids (RA), which are ligands for the nuclear RA receptor (RAR) family. RA were previously shown both to promote proliferation and to regulate apoptosis of thymocytes. In this study we detected the age-dependent mRNA expression of retinaldehyde dehydrogenases (RALDH1 and 2), cellular RA binding protein-II and CYP26A, proteins responsible for the synthesis, nuclear transport and degradation of RA in the postnatally developing thymus. RALDH1 was located in thymic epithelial cells. However, the amount of all-trans RA in thymic homogenates was close to the detection limit, suggesting that in this tissue all-trans RA is not the main RAR-regulating product of retinol metabolism. At the same time, by measuring the induction of a RAR-responsive transgene in two independent transgenic mouse strains, we demonstrated the production of an RAR-activating ligand, which was age and RALDH dependent. Our data provide evidence for the existence of endogenous retinoid synthesis in the thymus and suggest that retinoids similar to glucocorticoids might indeed be involved in the regulation of thymic proliferation and selection processes by being present in the thymus in functionally effective amounts.


Asunto(s)
Receptores de Ácido Retinoico/metabolismo , Linfocitos T/inmunología , Timo/crecimiento & desarrollo , Timo/inmunología , Tretinoina/metabolismo , Aldehído Oxidorreductasas/inmunología , Aldehído Oxidorreductasas/metabolismo , Animales , Apoptosis/inmunología , Sistema Enzimático del Citocromo P-450/inmunología , Sistema Enzimático del Citocromo P-450/metabolismo , Hibridación in Situ , Etiquetado Corte-Fin in Situ , Ligandos , Ratones , Ratones Transgénicos , Reacción en Cadena de la Polimerasa , ARN Mensajero/análisis , Receptores de Ácido Retinoico/inmunología , Ácido Retinoico 4-Hidroxilasa , Timo/metabolismo
8.
World J Gastroenterol ; 13(2): 316-9, 2007 Jan 14.
Artículo en Inglés | MEDLINE | ID: mdl-17226917

RESUMEN

The early hypersensitivity reaction and late bone marrow depression are well-known side-effects of azathioprine, whereas interstitial pneumonia is a rare complication. A 40-year old male patient had been treated with azathioprine in consequence of extensive ulcerative colitis for 10 years. He then complained of 7 d of fever, cough and catarrhal signs, without symptoms of active colitis. Opportunistic infections were ruled out. The chest X-ray, CT and lung biopsy demonstrated the presence of interstitial inflammation. Azathioprine therapy was discontinued as a potential source of the pulmonary infiltrate. In response to steroid therapy, and intensive care, the pulmonary infiltrate gradually decreased within 4 wk. Three months later, his ulcerative colitis relapsed, and ileo-anal pouch surgery was performed. In cases of atypical pneumonia, without a proven infection, azathioprine-associated interstitial pneumonitis may be present, which heals after withdrawal of the drug.


Asunto(s)
Azatioprina/efectos adversos , Colitis Ulcerosa/tratamiento farmacológico , Inmunosupresores/efectos adversos , Enfermedades Pulmonares Intersticiales/inducido químicamente , Enfermedades Pulmonares Intersticiales/diagnóstico , Adulto , Azatioprina/administración & dosificación , Humanos , Inmunosupresores/administración & dosificación , Enfermedades Pulmonares Intersticiales/patología , Masculino , Radiografía Torácica
9.
Eur J Immunol ; 36(6): 1559-71, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16673448

RESUMEN

Adenosine is generated in the microenvironment of emerging thymocytes through normal mechanisms of lymphocyte selection. In a normal thymus, most of the adenosine is catabolized by adenosine deaminase; however, in an environment where up to 95% of the cells undergo programmed cell death, a sufficient amount of adenosine is accumulated to trigger cell surface adenosine receptors. Here we show that accumulated adenosine can induce apoptosis in immature mouse thymocytes, mostly via adenosine A(2A) receptors. The signaling pathway is coupled to adenylate cyclase activation, induction of the Nur77 transcription factor, Nur77-dependent genes, such as Fas ligand and TRAIL, and the pro-apoptotic BH3-only protein Bim. We analyzed several knockout and transgenic mouse lines and found that adenosine-induced killing of mouse thymocytes requires Bim, occurs independently of "death receptor" signaling and is inhibited by Bcl-2 and Nur77. Collectively our data demonstrate that adenosine-induced cell death involves signaling pathways originally found in negative selection of thymocytes and suggest a determining role of Bim and a regulatory role for Nur77.


Asunto(s)
Adenilil Ciclasas/inmunología , Apoptosis/inmunología , Proteínas de Unión al ADN/inmunología , Receptor de Adenosina A2A/inmunología , Receptores Citoplasmáticos y Nucleares/inmunología , Receptores de Esteroides/inmunología , Linfocitos T/inmunología , Factores de Transcripción/inmunología , Adenosina/inmunología , Animales , Apoptosis/efectos de los fármacos , Proteína Proapoptótica que Interacciona Mediante Dominios BH3/genética , Proteína Proapoptótica que Interacciona Mediante Dominios BH3/inmunología , Western Blotting , AMP Cíclico/inmunología , Proteínas de Unión al ADN/genética , Proteína Ligando Fas , Masculino , Glicoproteínas de Membrana/inmunología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Ratones Transgénicos , Miembro 1 del Grupo A de la Subfamilia 4 de Receptores Nucleares , Proteínas Proto-Oncogénicas c-bcl-2/inmunología , ARN Mensajero/química , ARN Mensajero/genética , Receptores Citoplasmáticos y Nucleares/genética , Receptores de Esteroides/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Linfocitos T/citología , Linfocitos T/enzimología , Factores de Transcripción/genética , Factores de Necrosis Tumoral/inmunología
10.
Orv Hetil ; 147(6): 259-62, 2006 Feb 12.
Artículo en Húngaro | MEDLINE | ID: mdl-16610616

RESUMEN

Azathioprine-associated interstitial pneumonitis. The early hypersensitivity reaction and the late bone marrow depression are well known side effects of the azathioprine; the interstitial pneumonia is a rare complication. A 40-year old male patient was treated with azathioprine due to extensive ulcerative colitis for ten years. He complained seven days of fever, cough and catarrhal signs, without the symptoms of active colitis. The opportunistic infections were ruled out. Chest X-ray, CT and lung biopsy proved the presence of interstitial inflammation. The azathioprine therapy was discontinued as the potential source of the pulmonary infiltrate. As a result of steroid therapy, as well as emergency unit care, the pulmonary infiltrates decreased gradually. Three months later his ulcerative colitis relapsed, for this an ileo-anal pouch surgery was done. In case of atypical pneumonia, without proven opportunistic infection, azathioprine-associated interstitial pneumonitis may be present, which heal after cessation of the drug.


Asunto(s)
Azatioprina/efectos adversos , Inmunosupresores/efectos adversos , Enfermedades Pulmonares Intersticiales/inducido químicamente , Adulto , Azatioprina/administración & dosificación , Colitis Ulcerosa/tratamiento farmacológico , Colitis Ulcerosa/cirugía , Humanos , Inmunosupresores/administración & dosificación , Enfermedades Pulmonares Intersticiales/diagnóstico por imagen , Enfermedades Pulmonares Intersticiales/patología , Masculino , Radiografía
11.
Digestion ; 71(2): 92-6, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15775676

RESUMEN

AIM: Investigation of the prevalence of respiratory symptoms and diseases associated with gastroesophageal reflux disease (GERD). PATIENTS AND METHODS: 299 subjects with GERD were submitted to upper gastrointestinal endoscopy and 24-hour esophageal pH monitoring and a symptom analysis. RESULTS: Chronic respiratory symptoms or diseases were present in 18% (56/299). Chronic cough was observed in 42/56 patients, while typical reflux symptoms such as heartburn and acid regurgitation were observed in 30/56 and 24/56 cases, respectively. The prevalence of airway diseases was chronic bronchitis 12/56, asthma 10/56, recurrent pneumonia 10/56, chronic sinusitis 7/56 and chronic laryngitis 1/56. In patients with respiratory complications pathologic acid reflux was established in 29/51 cases on the basis of the DeMeester score, while 17/51 had pathologic postprandial, nocturnal or diurnal reflux events. Upper gastrointestinal endoscopy revealed a normal esophageal mucosa in 6/56, Savary-Miller stage I esophagitis in 23/56, stage II in 15/56, stage III in 5/56 and stage IV in 6/56 patients. CONCLUSIONS: These investigations have demonstrated an abnormal 24-hour pH score in about half of the patients with GERD-associated respiratory complications, and indicated that short reflux events are characteristic of the reflux activity in one third of this population.


Asunto(s)
Reflujo Gastroesofágico/complicaciones , Enfermedades Respiratorias/etiología , Adulto , Anciano , Endoscopía Gastrointestinal , Esófago/química , Femenino , Humanos , Concentración de Iones de Hidrógeno , Mucosa Intestinal/patología , Masculino , Persona de Mediana Edad , Prevalencia , Enfermedades Respiratorias/epidemiología
12.
Eur J Immunol ; 34(3): 827-836, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-14991612

RESUMEN

Cells from the CD4+ murine T hybridoma line IP-12-7 enter the apoptotic suicide program via the Fas ligand (FasL)/Fas-mediated pathway upon TCR stimulation. This stimulus regulates the sensitization of the Fas death pathway and the cell surface appearance of preformed FasL. The apoptosis is dependent on new mRNA and protein synthesis and involves up-regulation of nur77. Two groups of nuclear receptors for retinoic acids (RA) have been identified: retinoic acid receptors (RAR) and retinoid X receptors. IP-12-7 cells express RARalpha and RARgamma. Here we show that,in the IP-12-7 T cells, RA also induced the expression and DNA binding of nur77, and the cell surface appearance of FasL. The induction was mediated via RARgamma. Despite the induced expression of cell surface FasL, only two structurally related RARgamma-selective compounds, CD437 and CD2325, initiated apoptosis in these cells. The lack of apoptosis induction by natural RA was related to the inability of RARgamma to sensitize the Fas death-pathway. Cell surface FasL, however, was able to induce cell death in Fas-bearing target cells. Natural RA also induced the expression of FasL in phytohemagglutinin-activated peripheral murine T cells. It is proposed that therapeutically administered RA might induce apoptosis in Fas-sensitive cells via induction of FasL expression in activated Tcells.


Asunto(s)
Apoptosis , Proteínas de Unión al ADN/metabolismo , Glicoproteínas de Membrana/metabolismo , Receptores de Ácido Retinoico/agonistas , Retinoides/farmacología , Linfocitos T/inmunología , Factores de Transcripción/metabolismo , Animales , Supervivencia Celular , Células Cultivadas , Proteínas de Unión al ADN/fisiología , Proteína Ligando Fas , Hibridomas , Activación de Linfocitos , Ratones , Miembro 1 del Grupo A de la Subfamilia 4 de Receptores Nucleares , Receptores Citoplasmáticos y Nucleares , Receptores de Ácido Retinoico/metabolismo , Receptores de Esteroides , Receptores X Retinoide , Transducción de Señal , Linfocitos T/citología , Linfocitos T/efectos de los fármacos , Factores de Transcripción/fisiología , Receptor de Ácido Retinoico gamma
13.
Proc Natl Acad Sci U S A ; 100(13): 7812-7, 2003 Jun 24.
Artículo en Inglés | MEDLINE | ID: mdl-12810961

RESUMEN

Tissue transglutaminase (TGase2) is a protein-crosslinking enzyme known to be associated with the in vivo apoptosis program. Here we report that apoptosis could be induced in TGase2-/- mice; however, the clearance of apoptotic cells was defective during the involution of thymus elicited by dexamethasone, anti-CD3 antibody, or gamma-irradiation, and in the liver after induced hyperplasia. The lack of TGase2 prevented the production of active transforming growth factor-beta1 in macrophages exposed to apoptotic cells, which is required for the up-regulation of TGase2 in the thymus in vivo, for accelerating deletion of CD4+CD8+ cells and for efficient phagocytosis of apoptotic bodies. The deficiency is associated with the development of splenomegaly, autoantibodies, and immune complex glomerulonephritis in TGase2-/- mice. These findings have broad implications not only for diseases linked to inflammation and autoimmunity but also for understanding the interrelationship between the apoptosis and phagocytosis process.


Asunto(s)
Apoptosis , Proteínas de Unión al GTP/genética , Proteínas de Unión al GTP/fisiología , Macrófagos/metabolismo , Fagocitosis , Transglutaminasas/genética , Transglutaminasas/fisiología , Animales , Autoanticuerpos/metabolismo , Western Blotting , Linfocitos T CD4-Positivos/metabolismo , Linfocitos T CD8-positivos/metabolismo , Hepatocitos/metabolismo , Inmunoglobulina M/metabolismo , Listeria monocytogenes/metabolismo , Ratones , Microscopía Electrónica , Reacción en Cadena de la Polimerasa , Proteína Glutamina Gamma Glutamiltransferasa 2 , Saccharomyces cerevisiae/metabolismo , Timo/metabolismo , Timo/patología , Timo/ultraestructura , Factor de Crecimiento Transformador beta/metabolismo , Factor de Crecimiento Transformador beta1 , Regulación hacia Arriba
14.
J Immunol ; 170(7): 3577-84, 2003 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-12646620

RESUMEN

Negative selection refers to the selective deletion of autoreactive thymocytes. Its molecular mechanisms have not been well defined. Previous studies in our laboratory have demonstrated that retinoic acids, physiological ligands for the nuclear retinoid receptors, selectively inhibit TCR-mediated death under in vitro conditions, and the inhibition is mediated via the retinoic acid receptor (RAR) alpha. The present studies were undertaken to investigate whether ligation of RARalpha leads to inhibition of TCR-mediated death in vivo and to identify the molecular mechanisms involved. Three models of TCR-mediated death were studied: anti-CD3-mediated death of thymocytes in wild-type mice, and Ag- and bacterial superantigen-driven thymocyte death in TCR-transgenic mice expressing a receptor specific for a fragment of pigeon cytochrome c in the context of the E(k) (class II MHC) molecule. Our data demonstrate that the molecular program of both anti-CD3- and Ag-driven, but not that of superantigen-mediated apoptosis involves up-regulation of nur77, an orphan nuclear receptor, and bim, a BH3-only member of the proapoptotic bcl-2 protein family, proteins previously implicated to participate in the negative selection. Ligation of RARalpha by the synthetic agonist CD336 inhibited apoptosis, DNA binding of nur77, and synthesis of bim induced by anti-CD3 or the specific Ag, but had no effect on the superantigen-driven cell death. Our data imply that retinoids are able to inhibit negative selection in vivo as well, and they interfere with multiple steps of the T cell selection signal pathway.


Asunto(s)
Proteínas Portadoras/antagonistas & inhibidores , Proteínas de Unión al ADN/antagonistas & inhibidores , Proteínas de la Membrana , Proteínas Proto-Oncogénicas , Receptores de Ácido Retinoico/agonistas , Receptores de Ácido Retinoico/fisiología , Subgrupos de Linfocitos T/citología , Subgrupos de Linfocitos T/inmunología , Timo/citología , Timo/inmunología , Factores de Transcripción/antagonistas & inhibidores , Animales , Anticuerpos Monoclonales/administración & dosificación , Apoptosis/efectos de los fármacos , Apoptosis/inmunología , Proteínas Reguladoras de la Apoptosis , Proteína 11 Similar a Bcl2 , Benzoatos/administración & dosificación , Complejo CD3/inmunología , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/metabolismo , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/metabolismo , Proteínas Portadoras/biosíntesis , Supresión Clonal/efectos de los fármacos , Supresión Clonal/inmunología , Columbidae , Grupo Citocromo c/administración & dosificación , Grupo Citocromo c/inmunología , Proteínas de Unión al ADN/biosíntesis , Proteínas de Unión al ADN/metabolismo , Enterotoxinas/administración & dosificación , Inyecciones Intraperitoneales , Ligandos , Masculino , Ratones , Ratones Transgénicos , Miembro 1 del Grupo A de la Subfamilia 4 de Receptores Nucleares , Unión Proteica/efectos de los fármacos , Unión Proteica/inmunología , Receptores Citoplasmáticos y Nucleares , Receptores de Ácido Retinoico/metabolismo , Receptores de Esteroides , Receptor alfa de Ácido Retinoico , Retinoides/metabolismo , Staphylococcus aureus/inmunología , Superantígenos/administración & dosificación , Subgrupos de Linfocitos T/efectos de los fármacos , Subgrupos de Linfocitos T/metabolismo , Tetrahidronaftalenos/administración & dosificación , Timo/efectos de los fármacos , Timo/metabolismo , Factores de Transcripción/biosíntesis , Factores de Transcripción/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...